Trial Profile
Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2011
Price :
$35
*
At a glance
- Drugs Dacarbazine (Primary) ; Gemcitabine (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 27 Jun 2011 Status changed from not stated to completed.
- 05 Nov 2010 New trial record.